Fig. 1: ISL1 expression in primary GC tissues. | Cell Death & Disease

Fig. 1: ISL1 expression in primary GC tissues.

From: ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7

Fig. 1

a–c The expression of ISL1 in primary GC (T) and corresponding surgical margin (N) tissues was examined by RT-PCR (a), western blotting (b), and immunohistochemical staining (c). Original magnification: 200× in c. d Association between ISL1 expression status and TNM stage. e, f Kaplan–Meier survival curves of disease-free survival (DFS) and overall survival (OS) for patients with ISL1-negative vs. ISL1-positive staining in GC tissues

Back to article page